PreIPO
Private markets · Pre-IPO

How to invest in Anduril pre-IPO

Anduril is among the world's most sought-after private companies. Founded in 2017 and based in Costa Mesa, it operates in the “Aerospace & Defense” sector at an indicative valuation of ≈ $61B. This page explains how a qualified investor can register interest in exposure to Anduril ahead of its public listing.

Why Anduril is so sought-after

Autonomous defense — drones, AI command systems. Aerospace and defense attract massive private capital, driven by commercial space and sovereignty needs. Like most leaders in its category, Anduril is staying private far longer than companies once did: the bulk of value creation now happens before the listing, largely out of reach of the public markets.

Positioning in Anduril before the listing

Shares in Anduril are not publicly traded. Pre-IPO exposure runs through the private secondary market, reserved for qualified investors and subject to eligibility, due diligence and availability. Pre-IPO records your interest in Anduril and gets back to you within 48 hours to discuss market conditions. No transaction is completed on this site and no access is guaranteed.

Request access

Frequently asked questions — Anduril

Can you buy Anduril shares before the IPO?
Shares in a private company like Anduril are not listed. Acquiring them before an IPO involves secondary-market transactions reserved for qualified investors and subject to eligibility and availability. Pre-IPO records your interest but guarantees neither access nor price.
What is Anduril's valuation?
The latest known indicative valuation of Anduril is ≈ $61B, based on the most recent reported primary round or official tender. This figure is historical and does not imply any future price.
When will Anduril go public?
Anduril has not announced any IPO date. The timing rests solely with the company. Positioning early happens on the private market and carries the risk of total capital loss.

Other sought-after companies

Guides

Information only. No securities are offered or sold through this site. Pre-IPO is neither affiliated with nor a partner of Anduril; trademarks cited belong to their respective owners. Valuations are indicative and historical. Any private-market investment is illiquid and carries the risk of total capital loss. Access is reserved for qualified investors under Swiss law (FinSA).